What is MGI?
MGI Tech Co., Ltd. is dedicated to making effective and affordable healthcare solutions accessible to all. Leveraging its proprietary technology, the company designs, manufactures, and distributes a comprehensive suite of sequencing devices, equipment, consumables, and reagents. These offerings are crucial for advancing life science research, medicine, and healthcare. MGI's integrated multi-omics platforms encompass genetic sequencing, mass spectrometry, and medical imaging, providing real-time, comprehensive, and lifelong health insights. The company's commitment to innovation positions it as a key player in the global genomics and healthcare technology landscape.
How much funding has MGI raised?
MGI has raised a total of $1.4B across 3 funding rounds:
Series A
$200M
Unspecified
$200M
Series B
$1B
Series A (2019): $200M with participation from Orient Securities Capital Investment, Green Pine Capital Partners, and CITIC Securities
Unspecified (2019): $200M led by Green Pine Capital Partners, CITIC Goldstone Capital, and Orient Securities Capital Investment
Series B (2020): $1B supported by CPA and IDG Capital co
Key Investors in MGI
CPA
An undisclosed investor participating in the funding round, likely a strategic partner or financial institution.
IDG Capital co
An undisclosed investor participating in the funding round, potentially a venture capital firm with a focus on technology investments.
Green Pine Capital Partners
Green Pine Capital Partners is a venture capital firm established in 2007, based in ShenZhen, China, managing venture capital funds and providing investment and project management services.
What's next for MGI?
With a significant enterprise-level funding round and a recent strategic investment, MGI is poised for accelerated expansion and technological advancement. The company's focus on developing and promoting advanced life science tools, particularly in genetic sequencing and multi-omics, suggests a strategic direction towards enhancing diagnostic capabilities and personalized medicine. This capital will likely fuel further research and development, expand manufacturing capacity, and potentially broaden its global market reach. MGI's trajectory indicates a strong commitment to addressing critical healthcare needs through technological innovation.
See full MGI company page
